CDK9 and cervical cancer: Furthermore, our translational work with the small-molecule CDK9 inhibitor BAY1251152 [38] revealed that combining it with Cisplatin synergistically enhanced the sensitivity of Caspase-8 depleted cervical cancer cells to Cisplatin under both 2D- and 3D-cell culture conditions.